-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
-
Summary
-
ATAI Life Sciences N.V. quarterly/annual Revenues history and growth rate from Q1 2021 to Q2 2024.
- ATAI Life Sciences N.V. Revenues for the quarter ending June 30, 2024 was $273K, a 58.7% increase year-over-year.
- ATAI Life Sciences N.V. Revenues for the twelve months ending June 30, 2024 was $378K, a 39% increase year-over-year.
- ATAI Life Sciences N.V. annual Revenues for 2023 was $314K, a 34.8% increase from 2022.
- ATAI Life Sciences N.V. annual Revenues for 2022 was $233K, a 98.9% decline from 2021.
- ATAI Life Sciences N.V. annual Revenues for 2021 was $20.4M.
Revenues, Trailing 12 Months (USD)
Revenues, Quarterly (USD)
Revenues, YoY Quarterly Growth (%)